000 | 01193 a2200337 4500 | ||
---|---|---|---|
005 | 20250515220311.0 | ||
264 | 0 | _c20100805 | |
008 | 201008s 0 0 eng d | ||
022 | _a1873-5576 | ||
024 | 7 |
_a10.2174/156800910791208535 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXiao, Xiangshu | |
245 | 0 | 0 |
_aTargeting CREB for cancer therapy: friend or foe. _h[electronic resource] |
260 |
_bCurrent cancer drug targets _cJun 2010 |
||
300 |
_a384-91 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCyclic AMP Response Element-Binding Protein _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aProto-Oncogene Mas |
700 | 1 | _aLi, Bingbing X | |
700 | 1 | _aMitton, Bryan | |
700 | 1 | _aIkeda, Alan | |
700 | 1 | _aSakamoto, Kathleen M | |
773 | 0 |
_tCurrent cancer drug targets _gvol. 10 _gno. 4 _gp. 384-91 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800910791208535 _zAvailable from publisher's website |
999 |
_c19730472 _d19730472 |